Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 0.00 (-13.33%)
As of: Oct 21, 2026 · 12:27 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Change in Account Payables (2019 - 2020)

Updated

Adaptimmune Therapeutics (ADAPY) posted Change in Account Payables of $6.28 million for Q2 2020, up 298.2% from $1.58 million a year earlier.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Change in Account Payables (2019 - 2020) Analysis & Trends

For the trailing twelve months through Jun 30, 2020, Change in Account Payables at Adaptimmune Therapeutics was $2.7 million.

Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 6.28 Mn
Mar 31, 2020 -2.71 Mn
Jun 30, 2019 1.58 Mn
Mar 31, 2019 -2.45 Mn
API Access

Adaptimmune Therapeutics PLC Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=ADAPY&period=max&api_key=YOUR_API_KEY